首页> 美国卫生研究院文献>Scientific Reports >High-Throughput Microfluidic Platform for 3D Cultures of Mesenchymal Stem Cells Towards Engineering Developmental Processes
【2h】

High-Throughput Microfluidic Platform for 3D Cultures of Mesenchymal Stem Cells Towards Engineering Developmental Processes

机译:高通量微流控平台用于间充质干细胞的3D培养朝着工程开发过程发展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The development of in vitro models to screen the effect of different concentrations, combinations and temporal sequences of morpho-regulatory factors on stem/progenitor cells is crucial to investigate and possibly recapitulate developmental processes with adult cells. Here, we designed and validated a microfluidic platform to (i) allow cellular condensation, (ii) culture 3D micromasses of human bone marrow-derived mesenchymal stromal cells (hBM-MSCs) under continuous flow perfusion, and (ii) deliver defined concentrations of morphogens to specific culture units. Condensation of hBM-MSCs was obtained within 3 hours, generating micromasses in uniform sizes (56.2 ± 3.9 μm). As compared to traditional macromass pellet cultures, exposure to morphogens involved in the first phases of embryonic limb development (i.e. Wnt and FGF pathways) yielded more uniform cell response throughout the 3D structures of perfused micromasses (PMMs), and a 34-fold higher percentage of proliferating cells at day 7. The use of a logarithmic serial dilution generator allowed to identify an unexpected concentration of TGFβ3 (0.1 ng/ml) permissive to hBM-MSCs proliferation and inductive to chondrogenesis. This proof-of-principle study supports the described microfluidic system as a tool to investigate processes involved in mesenchymal progenitor cells differentiation, towards a ‘developmental engineering’ approach for skeletal tissue regeneration.
机译:开发体外模型以筛选不同浓度,组合和时间序列的形态调节因子对干/祖细胞的影响,对于研究并可能概括成年细胞的发育过程至关重要。在这里,我们设计并验证了一种微流体平台,该平台可以(i)允许细胞凝结,(ii)在连续的血流灌注下培养人骨髓源间充质基质细胞(hBM-MSC)的3D微团,以及(ii)提供一定浓度的形态发生素到特定的培养单位。 hBM-MSC的缩合在3分钟内完成,产生了大小一致的微团(56.2±3.9微米)。与传统的巨团团块培养相比,在胚胎肢体发育的第一阶段(即Wnt和FGF途径)中涉及的形态发生素的暴露在整个灌注微团块(PMM)的3D结构中产生了更为均匀的细胞反应,并且其比例提高了34倍在第7天检测增殖细胞。使用对数系列稀释生成器可以鉴定出hBM-MSC增殖并诱导软骨形成的TGFβ3的意外浓度(0.1μng/ ml)。这项原理验证研究支持上述微流控系统,该系统可作为研究涉及间充质祖细胞分化过程的工具,朝着“发育工程”的骨骼组织再生方法发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号